Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Brooks

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1981
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytesD A Brooks, I G Beckman, J Bradley, et al.
Biochimica Et Biophysica Acta|September 28, 1998
Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studiesS Bunge, P R Clements, S Byers, et al.
Human Mutation|January 1, 1992
alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotypeH S Scott, T Litjens, P V Nelson, et al.
Human Molecular Genetics|February 13, 2001
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulationK M Keeling, D A Brooks, J J Hopwood, et al.
Human Mutation|February 20, 2004
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapyL Karageorgos, P Harmatz, J Simon, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|June 13, 2001
Newborn screening for lysosomal storage disordersP J Meikle, E Ranieri, E M Ravenscroft, et al.
Journal of Developmental Origins of Health and Disease|July 13, 2017
Imaging and lipidomics methods for lipid analysis in metabolic and cardiovascular diseaseK G Stevens, C A Bader, A Sorvina, et al.
Molecular Genetics and Metabolism|March 6, 1999
Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cellsP J Meikle, M Yan, E M Ravenscroft, et al.
American Journal of Human Genetics|April 1, 1991
Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patientsD A Brooks, P A McCourt, G J Gibson, et al.
Clinical and Experimental Immunology|June 1, 1980
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. II. A hybridoma secreting antibody against an antigen expressed by human B and null lymphocytesI G Beckman, J Bradley, D A Brooks, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1981
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytesD A Brooks, I G Beckman, J Bradley, et al.
Biochimica Et Biophysica Acta|September 28, 1998
Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studiesS Bunge, P R Clements, S Byers, et al.
Human Mutation|January 1, 1992
alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotypeH S Scott, T Litjens, P V Nelson, et al.
Human Molecular Genetics|February 13, 2001
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulationK M Keeling, D A Brooks, J J Hopwood, et al.
Human Mutation|February 20, 2004
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapyL Karageorgos, P Harmatz, J Simon, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|June 13, 2001
Newborn screening for lysosomal storage disordersP J Meikle, E Ranieri, E M Ravenscroft, et al.
Journal of Developmental Origins of Health and Disease|July 13, 2017
Imaging and lipidomics methods for lipid analysis in metabolic and cardiovascular diseaseK G Stevens, C A Bader, A Sorvina, et al.
Molecular Genetics and Metabolism|March 6, 1999
Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cellsP J Meikle, M Yan, E M Ravenscroft, et al.
American Journal of Human Genetics|April 1, 1991
Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patientsD A Brooks, P A McCourt, G J Gibson, et al.
Clinical and Experimental Immunology|June 1, 1980
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. II. A hybridoma secreting antibody against an antigen expressed by human B and null lymphocytesI G Beckman, J Bradley, D A Brooks, et al.
Pageof 8